343 related articles for article (PubMed ID: 36357676)
1. Acute and postacute sequelae associated with SARS-CoV-2 reinfection.
Bowe B; Xie Y; Al-Aly Z
Nat Med; 2022 Nov; 28(11):2398-2405. PubMed ID: 36357676
[TBL] [Abstract][Full Text] [Related]
2. Postacute sequelae of COVID-19 at 2 years.
Bowe B; Xie Y; Al-Aly Z
Nat Med; 2023 Sep; 29(9):2347-2357. PubMed ID: 37605079
[TBL] [Abstract][Full Text] [Related]
3. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
Xie Y; Choi T; Al-Aly Z
JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
[TBL] [Abstract][Full Text] [Related]
4. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study.
Xie Y; Choi T; Al-Aly Z
BMJ; 2023 Apr; 381():e074572. PubMed ID: 37161995
[TBL] [Abstract][Full Text] [Related]
5. Risks and burdens of incident diabetes in long COVID: a cohort study.
Xie Y; Al-Aly Z
Lancet Diabetes Endocrinol; 2022 May; 10(5):311-321. PubMed ID: 35325624
[TBL] [Abstract][Full Text] [Related]
6. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.
Xu E; Xie Y; Al-Aly Z
Lancet Diabetes Endocrinol; 2023 Feb; 11(2):120-128. PubMed ID: 36623520
[TBL] [Abstract][Full Text] [Related]
7. Long-term neurologic outcomes of COVID-19.
Xu E; Xie Y; Al-Aly Z
Nat Med; 2022 Nov; 28(11):2406-2415. PubMed ID: 36138154
[TBL] [Abstract][Full Text] [Related]
8. Long COVID after breakthrough SARS-CoV-2 infection.
Al-Aly Z; Bowe B; Xie Y
Nat Med; 2022 Jul; 28(7):1461-1467. PubMed ID: 35614233
[TBL] [Abstract][Full Text] [Related]
9. Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in COVID-19 Survivors: A Retrospective Cohort Study.
Lim JT; Liang En W; Tay AT; Pang D; Chiew CJ; Ong B; Lye DCB; Tan KB
Clin Infect Dis; 2024 Jan; 78(1):70-79. PubMed ID: 37746872
[TBL] [Abstract][Full Text] [Related]
10. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
Nordström P; Ballin M; Nordström A
Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
[TBL] [Abstract][Full Text] [Related]
11. Risks of digestive diseases in long COVID: evidence from a population-based cohort study.
Ma Y; Zhang L; Wei R; Dai W; Zeng R; Luo D; Jiang R; Zhuo Z; Yang Q; Li J; Leung FW; Duan C; Sha W; Chen H
BMC Med; 2024 Jan; 22(1):14. PubMed ID: 38195495
[TBL] [Abstract][Full Text] [Related]
12. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
[TBL] [Abstract][Full Text] [Related]
13. Severity and Outcomes of SARS-CoV-2 Reinfection Compared with Primary Infection: A Systematic Review and Meta-Analysis.
Deng J; Ma Y; Liu Q; Du M; Liu M; Liu J
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834029
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study.
Xie Y; Choi T; Al-Aly Z
Lancet Infect Dis; 2024 Mar; 24(3):239-255. PubMed ID: 38104583
[TBL] [Abstract][Full Text] [Related]
15. Hospitalization, death, and probable reinfection in Peruvian healthcare workers infected with SARS-CoV-2: a national retrospective cohort study.
Ramos W; Guerrero N; Napanga-Saldaña EO; Medina J; Loayza M; De La Cruz-Vargas JA; Vargas M; Ordóñez L; Seclén-Ubillús Y; Álvarez-Antonio C; Arrasco J
Hum Resour Health; 2022 Dec; 20(1):86. PubMed ID: 36550511
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Medical and Mental Health Sequelae Following Hospitalization for COVID-19, Influenza, and Sepsis.
Quinn KL; Stukel TA; Huang A; Abdel-Qadir H; Altaf A; Bell CM; Cheung AM; Detsky AS; Goulding S; Herridge M; Ivers N; Lapointe-Shaw L; Lapp J; McNaughton CD; Raissi A; Rosella LC; Warda N; Razak F; Verma AA
JAMA Intern Med; 2023 Aug; 183(8):806-817. PubMed ID: 37338892
[TBL] [Abstract][Full Text] [Related]
17. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.
Carazo S; Skowronski DM; Brisson M; Sauvageau C; Brousseau N; Gilca R; Ouakki M; Barkati S; Fafard J; Talbot D; Gilca V; Deceuninck G; Garenc C; Carignan A; De Wals P; De Serres G
JAMA Netw Open; 2022 Oct; 5(10):e2236670. PubMed ID: 36239934
[TBL] [Abstract][Full Text] [Related]
18. First Cases of Sars-cov-2 Reinfection Coinciding with the Covid-19 Second Wave, Benin City, Nigeria.
Okwara BU; Osaigbovo II; Ogboghodo EO; Adio F; Oduware E; Obaseki DE; Asamah D
West Afr J Med; 2022 Aug; 39(8):777-780. PubMed ID: 36057812
[TBL] [Abstract][Full Text] [Related]
19. Three-year outcomes of post-acute sequelae of COVID-19.
Cai M; Xie Y; Topol EJ; Al-Aly Z
Nat Med; 2024 Jun; 30(6):1564-1573. PubMed ID: 38816608
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Infection and Postacute Risk of Non-Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged ≥50 Years.
Andersson NW; Thiesson EM; Lassaunière R; Hansen JV; Hviid A
Clin Infect Dis; 2024 Mar; 78(3):603-612. PubMed ID: 37740392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
